{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:36:08Z","timestamp":1790516168371,"version":"4.1.0"},"reference-count":52,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.2967\/jnumed.118.218008","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T22:45:14Z","timestamp":1560552314000},"page":"123-128","source":"Crossref","is-referenced-by-count":33,"title":["<sup>64<\/sup>Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist"],"prefix":"10.2967","volume":"61","author":[{"given":"Benjamin P.","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia S.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaline","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhanchi","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gon\u00e7alo S.","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D\u2019Huys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Ruest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juozas","family":"Domarkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Hubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Cawthorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Archibald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2019,6,14]]},"reference":[{"key":"2021051712142290000_61.1.123.1","doi-asserted-by":"publisher","DOI":"10.1038\/31269"},{"key":"2021051712142290000_61.1.123.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2003.10.003"},{"key":"2021051712142290000_61.1.123.3","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2263"},{"key":"2021051712142290000_61.1.123.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3182"},{"key":"2021051712142290000_61.1.123.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-010-9321-4"},{"key":"2021051712142290000_61.1.123.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162123"},{"key":"2021051712142290000_61.1.123.7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.celrep.2015.06.059","article-title":"CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation","volume":"12","author":"Roccaro","year":"2015","journal-title":"Cell Reports."},{"key":"2021051712142290000_61.1.123.8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320318110"},{"key":"2021051712142290000_61.1.123.9","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000002"},{"key":"2021051712142290000_61.1.123.10","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2013.71"},{"key":"2021051712142290000_61.1.123.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2010.09.011"},{"key":"2021051712142290000_61.1.123.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.24330"},{"key":"2021051712142290000_61.1.123.13","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000150856.47324.5b"},{"key":"2021051712142290000_61.1.123.14","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201100320"},{"key":"2021051712142290000_61.1.123.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.098798"},{"key":"2021051712142290000_61.1.123.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.151647"},{"key":"2021051712142290000_61.1.123.17","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404698"},{"key":"2021051712142290000_61.1.123.18","doi-asserted-by":"publisher","DOI":"10.7150\/thno.11251"},{"key":"2021051712142290000_61.1.123.19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7150\/thno.13986","article-title":"Ga-68-pentixafor-PET\/CT for imaging of chemokine receptor 4 expression in glioblastoma","volume":"6","author":"Lapa","year":"2016","journal-title":"Theranostics."},{"key":"2021051712142290000_61.1.123.20","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.18632\/oncotarget.7063","article-title":"Ga-68 pentixafor-PET\/CT for imaging of chemokine receptor 4 expression in small cell lung cancer: initial experience","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget."},{"key":"2021051712142290000_61.1.123.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161034"},{"key":"2021051712142290000_61.1.123.22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.nucmedbio.2014.04.081","article-title":"Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)","volume":"41","author":"Woodard","year":"2014","journal-title":"Nucl Med Biol."},{"key":"2021051712142290000_61.1.123.23","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.049775"},{"key":"2021051712142290000_61.1.123.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.06.010"},{"key":"2021051712142290000_61.1.123.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2010.08.009"},{"key":"2021051712142290000_61.1.123.26","doi-asserted-by":"publisher","DOI":"10.7150\/thno.5376"},{"key":"2021051712142290000_61.1.123.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2009.01.014"},{"key":"2021051712142290000_61.1.123.28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4396"},{"key":"2021051712142290000_61.1.123.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.085613"},{"key":"2021051712142290000_61.1.123.30","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-010-0466-y"},{"key":"2021051712142290000_61.1.123.31","doi-asserted-by":"publisher","DOI":"10.1021\/jm030383m"},{"key":"2021051712142290000_61.1.123.32","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1039\/a802060d","article-title":"Ultra rigid cross-bridged tetraazamacrocycles as ligands: the challenge and the solution","volume":"(16)","author":"Hubin","year":"1998","journal-title":"Chem Commun."},{"key":"2021051712142290000_61.1.123.33","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1039\/b406906d","article-title":"Ultrastable complexes for in vivo use: a bifunctional chelator incorporating a cross-bridged macrocycle","volume":"(19)","author":"Lewis","year":"2004","journal-title":"Chem Commun (Camb)."},{"key":"2021051712142290000_61.1.123.34","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.ccr.2010.02.025","article-title":"Biomedical applications of macrocyclic ligand complexes","volume":"254","author":"Mewis","year":"2010","journal-title":"Coord Chem Rev."},{"key":"2021051712142290000_61.1.123.35","doi-asserted-by":"crossref","unstructured":"Silversides JD Allan CC Archibald SJ . Copper(II) cyclam-based complexes for radiopharmaceutical applications: synthesis and structural analysis. Dalton Trans. 2007;971\u2013978.","DOI":"10.1039\/b615329a"},{"key":"2021051712142290000_61.1.123.36","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1039\/c0dt01395a","article-title":"Challenges in chelating positron emitting copper isotopes: tailored synthesis of unsymmetric chelators to form ultra stable complexes","volume":"40","author":"Silversides","year":"2011","journal-title":"Dalton Trans."},{"key":"2021051712142290000_61.1.123.37","doi-asserted-by":"publisher","DOI":"10.1021\/jm0103817"},{"key":"2021051712142290000_61.1.123.38","doi-asserted-by":"crossref","unstructured":"Woodin KS Heroux KJ Boswell CA . Kinetic inertness and electrochemical behavior of copper(II) tetraazamacrocyclic complexes: possible implications for in vivo stability. Eur J Inorg Chem. 2005;4829\u20134833.","DOI":"10.1002\/ejic.200500579"},{"key":"2021051712142290000_61.1.123.39","doi-asserted-by":"publisher","DOI":"10.1021\/ja807921k"},{"key":"2021051712142290000_61.1.123.40","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.1002\/chem.201601468","article-title":"Aspartate-based CXCR4 chemokine receptor binding of cross-bridged tetraazamacrocyclic copper(II) and zinc(II) complexes","volume":"22","author":"Maples","year":"2016","journal-title":"Chemistry."},{"key":"2021051712142290000_61.1.123.41","doi-asserted-by":"crossref","unstructured":"McRobbie G Valks GC Empson CJ . Probing key coordination interactions: configurationally restricted metal activated CXCR4 antagonists. Dalton Trans. 2007;5008\u20135018.","DOI":"10.1039\/b705800d"},{"key":"2021051712142290000_61.1.123.42","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1039\/c2dt31137b","article-title":"CXCR4 chemokine receptor antagonists: nickel(II) complexes of configurationally restricted macrocycles","volume":"41","author":"Smith","year":"2012","journal-title":"Dalton Trans."},{"key":"2021051712142290000_61.1.123.43","doi-asserted-by":"publisher","DOI":"10.1021\/jm0607810"},{"key":"2021051712142290000_61.1.123.44","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1002\/chem.200304808","article-title":"Selective recognition of configurational substrates of zinc cyclam by carboxylates: implications for the design and mechanism of action of anti-HIV agents","volume":"9","author":"Liang","year":"2003","journal-title":"Chemistry."},{"key":"2021051712142290000_61.1.123.45","doi-asserted-by":"publisher","DOI":"10.7150\/thno.4835"},{"key":"2021051712142290000_61.1.123.46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605642"},{"key":"2021051712142290000_61.1.123.47","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.10008"},{"key":"2021051712142290000_61.1.123.48","doi-asserted-by":"publisher","DOI":"10.1162\/153535003322556877"},{"key":"2021051712142290000_61.1.123.49","doi-asserted-by":"crossref","first-page":"e1254313","DOI":"10.1080\/2162402X.2016.1254313","article-title":"CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1\/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients","volume":"5","author":"D\u2019Alterio","year":"2016","journal-title":"Oncoimmunology."},{"key":"2021051712142290000_61.1.123.50","doi-asserted-by":"publisher","DOI":"10.2174\/138161207779313768"},{"key":"2021051712142290000_61.1.123.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2008.12.008"},{"key":"2021051712142290000_61.1.123.52","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1039\/C4DT02846E","article-title":"A nuclear chocolate box: the periodic table of nuclear medicine","volume":"44","author":"Blower","year":"2015","journal-title":"Dalton Trans."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.218008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:45:02Z","timestamp":1621284302000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.218008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,2]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.2967\/jnumed.118.218008"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.218008","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,14]]}}}